Contrast Media - Adverse effects
Research News and Information

Monday, November 23, 2009

Detection of clonal T cells in the circulation of patients with nephrogenic systemic fibrosis.

29 Sep 2009 BACKGROUND: Nephrogenic systemic fibrosis is a sclerodermalike disease in patients with acute or chronic renal insuffiency related to administration of gadolinium-containing contrast agents. Previous studies have demonstrated clonal T-cell ... Read more...

Gadolinium-associated nephrogenic systemic fibrosis.

29 Sep 2009 Nephrogenic systemic fibrosis is a progressive, potentially fatal multiorgan system fibrosing disease related to exposure of patients with renal failure to the gadolinium-based contrast agents used in magnetic resonance imaging. Because of this ... Read more...

Provider knowledge of contrast-induced acute kidney injury.

29 Sep 2009 BACKGROUND: Although past research has elucidated the principal risk factors and efficacy of preventive interventions for contrast-induced acute kidney injury (CIAKI), provider awareness of this empiric evidence base is largely unknown. We sought to ... Read more...

Latest indexed articles for 'Contrast Media - Adverse effects'

These are the very latest articles for this heading:

• Estimates of risk, empirical treatment observations, and unexpected laboratory findings reveal the complexity of nephrogenic systemic fibrosis. 29 Sep 2009
• Detection of clonal T cells in the circulation of patients with nephrogenic systemic fibrosis. 29 Sep 2009
• Gadolinium-associated nephrogenic systemic fibrosis. 29 Sep 2009
• Provider knowledge of contrast-induced acute kidney injury. 29 Sep 2009
• Free gadolinium is a likely trigger of nephrogenic systemic fibrosis. 29 Sep 2009
• Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure. 29 Sep 2009
• Contrast-induced nephropathy: we need all the data to discern the truth. 29 Sep 2009
• Renal protective effects and prevention of contrast-induced nephropathy by atrial natriuretic peptide can it work? 20 Sep 2009
• Lack of nephrotoxicity of gadodiamide in unselected hospitalized patients. 30 Aug 2009
• How to avoid nephrogenic systemic fibrosis: current guidelines in Europe and the United States. 30 Aug 2009
• Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update. 30 Aug 2009
• Nephrogenic systemic fibrosis: histology and gadolinium detection. 30 Aug 2009
• Nephrogenic systemic fibrosis: clinical picture and treatment. 30 Aug 2009
• Nephrogenic systemic fibrosis: history and epidemiology. 30 Aug 2009
• Prevention of contrast-induced nephropathy: an overview. 30 Aug 2009
• Contrast-induced nephropathy after intravenous administration: fact or fiction? 30 Aug 2009
• Contrast-induced acute kidney injury (CIAKI). 30 Aug 2009
• Contrast-induced nephropathy and nephrogenic systemic fibrosis. Preface. 30 Aug 2009
• Is interleukin-2 therapy still a risk factor for adverse reactions in concert with iodinated contrast medium injection? 30 Aug 2009
• The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Contrast Media'

Definition: Substances used to allow enhanced visualization of tissues.

Registry Number: 0

Descriptor UI: D003287

Alternative terms: Contrast Media; Media, Contrast; Radiopaque Media; Media, Radiopaque; Contrast Agents; Agents, Contrast; Contrast Materials; Materials, Contrast;

Related Mesh Headings: Extravasation of Diagnostic and Therapeutic Materials;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; chemical synthesis; classification; diagnostic use; economics; history; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; chemistry; contraindications;

Tree Number: D27.720.259;

Technical Notes: /adv eff: consider also EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS